Close
4

Seqens Seqens

X

Company profile for LoQus23 Therapeutics

  • Webinars & Exhibitions

PharmaCompass
About the Company
Related CompaniesRelated Companies
At LoQus23, our expert team is taking a structure-based approach to mismatch repair drug discovery, investigating small molecule drugs that could stop DNA instability and therefore slow neurodegeneration in Huntington’s disease, myotonic dystrophy type 1 and similar triplet repeat expansion diseases. Oral small molecule drugs have a strong track record in treating complex brain diseases and provide greater convenience for pa...
At LoQus23, our expert team is taking a structure-based approach to mismatch repair drug discovery, investigating small molecule drugs that could stop DNA instability and therefore slow neurodegeneration in Huntington’s disease, myotonic dystrophy type 1 and similar triplet repeat expansion diseases. Oral small molecule drugs have a strong track record in treating complex brain diseases and provide greater convenience for patients compared with other treatment approaches.

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Send me more info on How To Grow My Bussiness Digitally?
LoQus23 Therapeutics
unitedkingdom_new Flag
Country
Country
United Kingdom
Address
Address
Building 522 Babraham Research Campus Cambridge CB22 3AT
Telephone
Telephone
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY